The earliest stage of drug discovery is governed by a simple constraint: there are far more possible drug-like molecules than any pharmaceutical laboratory could ever test. A new deep learning system, ...
A new study published in the journal Minerals sheds light on this sweeping shift. Titled Big Data and AI in Geoscience: From ...
Researchers used AI and deep learning to find a link between brain structure and navigation skills but found no measurable ...
When the performance of AI models was assessed within stratified patient subgroups, such as only high-grade breast cancers or only MSI-positive tumors, accuracy fell substantially, revealing that the ...
What was once experimental research is now becoming operational backbone across modern energy systems. In the editorial ...
A Study shows mutation-resistant antibodies with 269×affinity, a proof point for CEPI’s 100 Days Mission and closing ...
As enterprise digital transformation advances with increasing depth and precision, the ability to efficiently manage and ...
Foundry's Nuke 17.0 brings native Gaussian Splat support, a production-ready USD-based 3D system, and the new BigCat machine learning node for large-scale VFX compositing.
Spire.AI Empollination and CrossKnowledge Capabl partner to deliver contextual learning aligned to evolving enterprise ...
Druva introduced Deep Analysis Agents, Agentic Memory and multimodal capabilities to move DruAI from conversational assistance to delegated investigative workflows.
"Dosing the first patient in Phase III represents a major milestone for MDR-001 and for AI-enabled drug development," said Zhangming Niu, Founder and Chief Executive Officer of MindRank. "We believe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results